- Home
- FLNT vs ALGS Comparison
FLNT vs ALGS Comparison
Compare FLNT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ALGS
- Stock Information
- Founded
- FLNT 2001
- ALGS 2018
- Country
- FLNT United States
- ALGS United States
- Employees
- FLNT N/A
- ALGS N/A
- Industry
- FLNT Advertising
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- ALGS Health Care
- Exchange
- FLNT Nasdaq
- ALGS Nasdaq
- Market Cap
- FLNT 39.2M
- ALGS 36.0M
- IPO Year
- FLNT N/A
- ALGS 2020
- Fundamental
- Price
- FLNT $1.87
- ALGS $7.98
- Analyst Decision
- FLNT Hold
- ALGS Strong Buy
- Analyst Count
- FLNT 1
- ALGS 1
- Target Price
- FLNT $3.00
- ALGS $70.00
- AVG Volume (30 Days)
- FLNT 21.6K
- ALGS 134.3K
- Earning Date
- FLNT 08-18-2025
- ALGS 08-05-2025
- Dividend Yield
- FLNT N/A
- ALGS N/A
- EPS Growth
- FLNT N/A
- ALGS N/A
- EPS
- FLNT N/A
- ALGS N/A
- Revenue
- FLNT $243,850,000.00
- ALGS $3,270,000.00
- Revenue This Year
- FLNT N/A
- ALGS N/A
- Revenue Next Year
- FLNT $11.62
- ALGS $51.55
- P/E Ratio
- FLNT N/A
- ALGS N/A
- Revenue Growth
- FLNT N/A
- ALGS N/A
- 52 Week Low
- FLNT $1.50
- ALGS $3.76
- 52 Week High
- FLNT $3.83
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- FLNT 45.96
- ALGS 64.99
- Support Level
- FLNT $1.78
- ALGS $7.43
- Resistance Level
- FLNT $1.90
- ALGS $8.36
- Average True Range (ATR)
- FLNT 0.09
- ALGS 0.73
- MACD
- FLNT 0.02
- ALGS 0.20
- Stochastic Oscillator
- FLNT 51.85
- ALGS 94.08
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.